Skip to content

About Us
- About Us
- Team
- Careers
- Investors
- Collaborations
Our Technology
- Our Technology
- Our Device
Applications
News
Contact Us

Menu

About Us
- About Us
- Team
- Careers
- Investors
- Collaborations
Our Technology
- Our Technology
- Our Device
Applications
News
Contact Us

News

August 30, 2022

Santersus AG in combination with their institutional partners our extremely proud to present the newest findings regarding the success in the Ex Vivo lung perfusion studies.

REMOVAL-OF-NEUTROPHIL-EXTRACELLULAR Download

Related links

About Santersus

https://www.santersus.com/

About VolitionRx Limited

https://www.volition.com/

If you would like to learn more about our technology, please contact Santersus team at info@santersus.com

Santersus AG Showcases Innovation in Brain Health at BRAIN Conference 2024

December 10, 2024

Santersus AG Achieves Breakthrough in Lung Transplantation Research

October 22, 2024

Santersus AG Wins National Abstract Award at UK ECPR Summit for Groundbreaking Research in Critical Care

September 26, 2024

Santersus AG Presented at the 2024 International Congress of ILTS in Houston, Texas

July 30, 2024

Santersus AG continues to present the latest work across the globe, presenting at conferences in Berlin, Rotterdam, Athens, and Milan

November 14, 2023

Page1 Page2 Page3 Page4

CONTACT US

Santersus AG,
c/o Lex Futura AG, Schützengasse 4
8001 Zürich, Switzerland

+ 41 44 586 3656
info@santersus.com

LEGAL

View our full disclaimer